Metastases develop in 30% to 40% of patients with operable breast cancer. Investigators have reported on the detection of occult micrometastases in bone marrow using an antibody to epithelial membrane antigen (EMA) and have since reported prognostic significance for these antibody-detected cells. In
Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer
✍ Scribed by Marie-Christine Mathieu; Sam Friedman; Jacques Bosq; Bernard Caillou; Marc Spielmann; Jean-Paul Travagli; Geneviève Contesso
- Publisher
- Springer US
- Year
- 1990
- Tongue
- English
- Weight
- 446 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We used a combination of bone and bone-marrow scintigraphy to study 25 patients with prostatic cancer. Of the 18 cases whose 99mTc-methylene diphosphonate (MDP) bone scans showed hot spots in the lower lumbar region of the spine and/or the pelvic bone, 8 had normal bone-marrow scintigrams. These 8 p
Estrogen receptor determination in metastatic breast cancer has been shown to be important in determining potential for response to endocrine therapy. One limitation to this procedure can be the availability of neoplastic material for receptor assay. This report describes patients in whom estrogen r